Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Tritax Big Box reported earnings drop, net rental income grows

(Sharecast News) - Logistics-focused landlord Tritax Big Box REIT said on Wednesday that it had delivered a solid H1 performance, with rental growth, development momentum, and a strategic pivot into data centres helping offset a dip in reported earnings. Tritax said net rental income rose 17.3% to £149.2m, lifting operating profits 16.4% to £144.1m, and adjusted earnings per share 6.4% to 4.63p. It also said its portfolio value climbed from ££6.55bn to £6.82bn, supported by stable yields and development gains.

However, Tritax noted that IFRS earnings per share had fallen 26.5%, reflecting non-recurring items and higher costs linked to its recent acquisition of UKCM.

Tritax flagged a 28.9% rental reversion opportunity across its logistics portfolio, with £64m of upside expected to be captured within three years.

Development activity added £5.6m to contracted rent, with 2.5m square feet under construction and strong pre-let interest and also noted that it had secured its second major data centre site, targeting yields of up to 11% and £25m in annual rent.

Tritax added that its loan-to-value ratio had risen to 30.9%, though it said disposals totalling £278m year-to-date would help self-fund future growth.

Cairman Aubrey Adams said: "Our resilient income profile is underpinned by long-duration contracted revenues, from strong clients on triple-net leases, while our three clear growth drivers provide the potential to grow adjusted earnings by 50% by the end of 2030.

"Recent development letting activity evidences the growing occupational interest in our sites - momentum we expect to build in the second half of the year."

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.